The pharmaceutical industry is racing to deploy AI on top of commercial data foundations that aren't ready for it. Field force realignments take a quarter to surface in dashboards. The same HCP appears under three identities across systems. "Market share" means one thing in CRM, another in sales reporting, and something else again to brand teams. AI built on that foundation doesn't just disappoint — it misleads, confidently and at scale.

This is a practitioner's guide to fixing the foundation before the AI investment lands on top of it.

Drawing on twenty-five years of commercial data leadership at some of the world's leading pharmaceutical and biotech firms, Karthik Chidambaram lays out an opinionated, end-to-end framework for building data infrastructure that AI can actually use. The figures throughout are drawn deliberately simply — sketched, as the back cover puts it, on the back of a paper napkin — because real strategy clarifies, it doesn't decorate.

Inside, you'll find:

The five-layer reference architecture every commercial pharma organization needs — and the optional sixth layer for agentic AI
Why the semantic layer is the linchpin, and how to build one that survives reorganizations, vendor changes, and platform migrations
The HCP 360 maturity model: from fragmented data to AI-ready, with concrete NPI match-rate milestones (target: 98%)
A three-phase roadmap with realistic 12–18 month timelines and the investment case to take to leadership
The "fragmentation tax": a method to quantify what poor data quality is costing your organization right now
The commercial agent maturity model — assisted, advisory, and autonomous — and what each demands of your data foundation
Governance designed for AI use: privacy constraints, permitted use cases, and audit trails for AI-generated decisions

Written for:

Commercial data and analytics leaders in pharma and biotech
Enterprise architects designing the next generation of commercial data platforms
Heads of commercial operations, brand, and IT planning AI investment
Executives building the business case for foundational data work

This is not a survey of AI hype. It is the strategy and architecture playbook for the data leaders who will actually have to deliver on it.

The technology will change. The principles will not.